References
- Campbell PJ, Green AR. The myeloproliferative disorders. N Engl J Med 2006; 355: 2452-66. 10.1056/NEJMra063728
- Hasselbalch HC. Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood 2012; 119: 3219-25. 10.1182/ blood-2011-11-394775
- Hasselbalch H. Idiopathic myelofibrosis: a clinical study of 80 patients. Am J Hematol 1990; 34: 291-300.
- Kristinsson SY, Landgren O, Samuelsson J, Björkholm M, Goldin LR. Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica. 2010; 95: 1216-20. 10.3324/haematol.2009.020412
- Koschmieder S, Mughal TI, Hasselbalch HC, Barosi G, Valent P, Kiladjian JJ, et al. Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both. Leukemia 2016; 30:1018-24. 10.1038/leu.2016.12
- Fleischman AG. Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm. Mediators Inflamm 2015: 2015: 606819. 10.1155/2015/606819
- Hermouet S, Bigot-Corbel E, Gardie B. Pathogenesis of Myeloproliferative Neoplasms: Role and Mechanisms of Chronic Inflammation. Mediators Inflamm 2015; 2015:145293. 10.1155/2015/145293
- Sørensen AL, Hasselbalch HC. Antecedent cardiovascular disease and autoimmunity in Philadelphia-negative chronic myeloproliferative neoplasms. Leuk Res 2016; 41:27-35. 10.1016/j.leukres.2015.11.017
- Hasselbalch HC, Bjørn ME. MPNs as inflammatory diseases: the evidence, consequences, and perspectives. Mediators Inflamm 2015; 2015: 102476. 10.1155/2015/102476
- Saif MW, Khan U, Greenberg BR. Cardiovascular manifestations of myeloproliferative disorders: a review of the literature. Hosp Physician 1999; 35: 43-54.
- Rossi C, Randi L, Zerbinati P, Rinaldi V, Girolami A. Acute coronary disease in essential thrombocytemia and polycythemia vera. J Intern Med 1998; 244: 49-53.
- Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 1999; 340: 115–26. 10.1056/NEJM199901143400207
- Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol 2011; 12: 204-12. 10.1038/ni.2001
- Landolfi R, Di Gennaro L. Pathophysiology of thrombosis in myeloproliferative neoplasms. Haematologica 2011; 96: 183-6. 10.3324/haematol.2010.038299
- Fleischman AG, Aichberger KJ, Luty SB, Bumm TG, Petersen CL, Doratotaj S, et al. Tumor necrosis factor-alpha facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms. Blood 2011; 118: 6392-98. 10.1182/blood-2011-04-348144
- Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al. European Network for Non-invasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-605. 10.1093/ eurheartj/ehl254
- Nuñez F, Martínez-Costa C, Sanchez-Zahonero J, Morata J, Chorro FJ, Brines J. Carotid artery stiffness as an early marker of vascular lesions in children and adolescents with cardiovascular risk factors. Rev Esp Cardiol 2010; 63:1253-60.
- Cote AT, Phillips AA, Harris KC, Sandor GGS, Panagiotopoulos C, Devlin AM. Obesity and arterial stiffness in children. Systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2015; 35:1038-44. 10.1161/ ATVBAHA.114.305062
- Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, et al. The assessment of endothelial function - from research into clinical practice. Circulation 2012;126: 753-67. 10.1161/ CIRCULATIONAHA.112.093245
- Halcox JP, Donald AE, Ellins E, Witte DR, Shipley MJ, Brunner EJ, et al. Endothelial function predicts progression of carotid intima-media thickness. Circulation 2009; 119:1005–12. 10.1161/CIRCULATIONAHA.108.765701
- Hecht HS. Coronary artery calcium scanning – past, present and future. JACC Cardiovasc Img 2015; 8: 579-96. 10.1016/j.jcmg.2015.02.006
- D’Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM et al. General cardiovascular risk profile for use in primary care – the Framingham Heart Study. Circulation 2008; 117: 743-52. 10.1161/ CIRCULATIONAHA.107.699579
- Availabe at: http:// cvrisk.mvm.ed.ac.uk/calculator/riskcalculator.xls. Accessed: Sep 7, 2016.
- Hollander M, Bots ML, Iglesias del Sol A, Koudstaal PJ, Witteman JCM, Grobbee DE, et al. Carotid plaques increase the risk of troke and subtypes of cerebral infarction in asymptomatic elderly – the Rotterdam Study. Circulation 2002; 105: 2872-7.
- Hayashi K, Handa H, Nagasawa S, Okumura A, Moritake K. Stiffness and elastic behavior of human intracranial and extracranial arteries. J Biomech 1980; 13:175–184.
- Aloka, ultrasound diagnostic instrument, prosound α7, instruction manual, how to use (volume 2/2) MN 1 – 5369 rev. 9: 140-9.
- Agatston AS, Janowitz WR, Hilander FJ, Zusmer RN, Viamonte M, Detrow R. Qunatification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-32.
- Axtell AL, Gomari FA, Cooke JP. Assessing endothelial vasodilator function with the Endo-PAT 2000. J Vis Exp 2010; 44: e2167,10.3791/2167
- Arad Y, Spadaro LA, Goodman K, NewsteinD, Guerci AD. Prediction of coronary events with electron beam computed tomography. J Am Col Cardiol 2000; 36: 1253-60.
- Hayashi K, Yamamoto T, Takahara A, Shirai K. Clinical assessment of arterial stiffness with cardio-ankle vascular index: theory and application. J Hypertens 2015; 33: 1742-57. 10.1097/HJH.0000000000000651
- Blacher J, Pannier B, Guerin A, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension 1998; 32: 570–574.
- Barenbrock M, Kosch M, Joster E, Kisters K, Rahn K, Hausberg M. Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J Hypertens 2002; 20:79–84.
- Dijk JM, Algra A, van der Graff Y, Grobbee DE, Bots ML, SMART study group. Carotid stiffness and the risk of new vascular events in patients with manifest cardiovascular disease. The SMART study. Eur Heart J 2005; 26:1213–1220. 10.1093/eurheartj/ehi254
- Celermajer DS. Reliable endothelial function testing : at our fingertips? Circulation 2008, 117: 2428-30. 10.1161/CIRCULATIONAHA.108.775155
- Hamburg NM, Keyes MJ, Larson MG, Vasan RS, Schnabel R, Pryde MM, et al.. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 2008;117: 2467–74. 10.1161/CIRCULATIONAHA.107.748574